2021's challenges for journalism
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Axios cofounder and CEO Jim VandeHei joins Axios Re:Cap senior producer Naomi Shavin to talk about what journalists got right and wrong in 2021 and what challenges lie ahead for the industry next year. Learn more about your ad choices. Visit megaphone.fm/adchoices
The year psychedelics went mainstream
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major research trend that flew under the radar this year: increased public and private funding for trials looking into therapeutic psychedelics. Learn more about your ad choices. Visit megaphone.fm/adchoices
Behind the scenes of How It Happened Season 3
Axios Re:Cap presents a conversation between Axios Today host Niala Boodhoo and Axios Tel Aviv reporter Barak Ravid about the third season of How It Happened: Trump's Big Deal. Learn more about your ad choices. Visit megaphone.fm/adchoices
Biden's big immigration challenges
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Policy and demographics reporter Stef Kight joins Axios Re:Cap senior producer Naomi Shavin to discuss the immigration challenges President Biden faces and how his policies are playing out at the U.S. southern border and among his critics. Learn more about your ad choices. Visit megaphone.fm/adchoices
Reflecting on our second year of COVID
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Health care reporter Caitlin Owens joins Axios Re:Cap senior producer Naomi Shavin to discuss living alongside COVID in 2021 and all of the vaccine, antiviral and variant developments this year brought. Learn more about your ad choices. Visit megaphone.fm/adchoices